The OpenVAERS Project

VAERS is the Vaccine Adverse Event Reporting System put in place in 1990. It is a voluntary reporting system that has been estimated to account for only 1% ( see the Lazarus Report) of vaccine injuries. OpenVAERS is built from the HHS data available for download at vaers.hhs.gov.

The OpenVAERS Project allows browsing and searching of the reports without the need to compose an advanced search (more advanced searches can be done at medalerts.org or vaers.hhs.gov). To start searching OpenVAERS, please use the red button below.

Reports are current through October 15, 2021.

All fields can be combined as filters. Each search term will narrow the search. The text fields can accept only a single search term.

V-Safe Reports Only

Report Received
Deceased
State
Gender
Age Range
can also be used as a min or max age
VAERS ID:
Vax Type:
eg. "DTP" or "MMR"
Vax Name:
eg. "covid19" or "gardasil"
Symptom:
Description:

Page 2 of 16157 Results 11 - 20 of 161568

Deceased
Recovered
VAERS ID: 1000264
AGE: 40 SEX: F

This is a spontaneous report from two contactable physicians, A 40-year-old female patient received the 1st dose of vaccine expiration date: 30Apr2021, intramuscular on 06Jan2021 at single dose for covid-19 immunisation. The patient medical history included anaphylaxis after IV penicillin according to the patient from an unknown date and not ongoing, ongoing shoulder pain chronic. The patient's concomitant medications included levonorgestrel (KYLEENA) from 29Oct2018 to an unknown date for contraception, …
Read FULL REPORT >


VACCINE TYPE(S): COVID19
VACCINE NAME(S): COVID19 (COVID19 (PFIZER-BIONTECH))


SYMPTOM(S): Anaphylactic reaction, Oxygen saturation, Blood pressure measurement, Tachycardia, Cough, Tryptase, Flushing, Heart rate

VAERS ID: 1000265
AGE: UNK SEX: F

Post vaccination satellite lesions; Hypoaesthesia; Severe pain in administration site (Left upper limb); This is a spontaneous report from a contactable physician downloaded from the Regulatory Authority-WEB and received via Regulatory Authority ES-AEMPS-714048. A 26-year-old female patient received the 1st dose of bnt162b2 (COMIRNATY, lot # unknown) at single dose at left upper limb on 08Jan2021 for covid-19 immunisation, as being a health care professional or social health center staff. Medical …
Read FULL REPORT >


VACCINE TYPE(S): COVID19
VACCINE NAME(S): COVID19 (COVID19 (PFIZER-BIONTECH))


SYMPTOM(S): Hypoaesthesia, SARS-CoV-2 test positive, Vaccination complication, Vaccination site pain

VAERS ID: 1000266
AGE: UNK SEX: F

This is a spontaneous report downloaded from a contactable physician. This physician reported 2 reports for different patients. This is the 1st of 2 reports. An 80-year-old female patient received the 1st dose of vaccine via an unspecified route of administration, in Jan2021, at single dose, for COVID-19 immunisation. Medical history included neuropsychiatric symptoms and COVID-19 in 2020 (COVID-19 PCR virus: positive on 22Oct2020). Concomitant medications were not reported. The patient experienced …
Read FULL REPORT >


VACCINE TYPE(S): COVID19
VACCINE NAME(S): COVID19 (COVID19 (PFIZER-BIONTECH))


SYMPTOM(S): Depressed level of consciousness, Pyrexia, SARS-CoV-2 test, Seizure

VAERS ID: 1000272
AGE: UNK SEX: F

This is a spontaneous report from a contactable pharmacist and other healthcare professional received through a Regional Market Access Manager Pfizer Colleague. A 34-year-old female patient received first dose of BNT162B2 (COMIRNATY, Batch # PAA 156571, LOT # EJ6796, Exp: 30Apr2021) intramuscular 0.3ml at single dose at deltoid on 30Dec2020 13:15 for COVID-19 vaccination. The patient's medical history included tonsillitis from 18Dec2020 to 22Dec2020 treated with ibuprofen and azithromycin. Patient …
Read FULL REPORT >


VACCINE TYPE(S): COVID19
VACCINE NAME(S): COVID19 (COVID19 (PFIZER-BIONTECH))


SYMPTOM(S): Activated partial thromboplastin time, Blood creatinine, Blood thromboplastin, Ear, nose and throat examination, Haemoglobin, Mean cell haemoglobin, Muscular weakness, Platelet count, Vomiting, Anaphylactic reaction, Blood fibrinogen, Blood urea, Electrocardiogram, Heart rate, Mean cell haemoglobin concentration, Nausea, Platelet distribution width, White blood cell count, Anxiety, Blood glucose, Body temperature increased, Eosinophil count, International normalised ratio, Mean cell volume, Neutrophil count, Prothrombin time, Auscultation, Blood pressure measurement, Coma scale, Fatigue, Investigation, Mean platelet volume, Oxygen saturation, Red blood cell analysis, Basophil count, Blood sodium, Diarrhoea, Haematocrit, Lymphocyte count, Monocyte count, Physical examination, Red blood cell count

VAERS ID: 1000282
AGE: UNK SEX: M

Infarct myocardial; Diffuse coronary disease; Feeling sick; This is a spontaneous report from a contactable physician downloaded from the WEB regulatory authority FR-AFSSAPS-PV20210074. A 72-year-old male patient received bnt162b2 (COMIRNATY, lot: EJ6795), intramuscularly on 12Jan2021 at 0.3 ml single dose on left arm for COVID-19 immunisation. Medical history included ongoing respiratory failure and ongoing probable diffuse coronary disease; pneumonia, bronchitis chronic and minimal bronchial dilation, …
Read FULL REPORT >


VACCINE TYPE(S): COVID19
VACCINE NAME(S): COVID19 (COVID19 (PFIZER-BIONTECH))


SYMPTOM(S): Coronary artery disease, Malaise, Myocardial infarction

VAERS ID: 1000284
AGE: UNK SEX: F

Infarct myocardial; This is a spontaneous report from a contactable consumer downloaded from the Regulatory Authority -WEB FR-AFSSAPS-RN20210156. A 49-year-old female patient received the 2nd dose of bnt162b2 (COMIRNATY, lot number: EM0477) via intramuscular at right deltoid on 12Jan2021 at single dose for covid-19 vaccination. Medical history included no particular history other than overweight (BMI: 28.5). Concomitant medications were unknown. The patient previously received the 1st dose of bnt162b2 …
Read FULL REPORT >


VACCINE TYPE(S): COVID19
VACCINE NAME(S): COVID19 (COVID19 (PFIZER-BIONTECH))


SYMPTOM(S): Body mass index, Myocardial infarction

VAERS ID: 1000290
AGE: UNK SEX: F

medication error; Anaphylactic reaction; Pulmonary edema; This is a spontaneous report from a contactable consumer (patient). This is a report received from the Regulatory Agency. Regulatory authority report number is GB-MHRA-EYC 00237518, Safety Report Unique Identifier: GB-MHRA-ADR 24581820. A 39-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/Batch: EE8493), parenteral on 11Jan2021 at single dose for COVID-19 vaccination. Medical history included ongoing multiple …
Read FULL REPORT >


VACCINE TYPE(S): COVID19
VACCINE NAME(S): COVID19 (COVID19 (PFIZER-BIONTECH))


SYMPTOM(S): Anaphylactic reaction, Contraindicated product administered, Pulmonary oedema

VAERS ID: 1000318
AGE: UNK SEX: M

Seizure; Gastroenteritis; This is a spontaneous report received from a contactable consumer received by Pfizer from the Regulatory Authority. The regulatory authority report number is GB-MHRA-ADR 24608875 and GB-MHRA-WEBCOVID-202101181222255460. A 70-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 16Jan2021 at single for covid-19 immunisation. Lot number was ELO 739. The medical history and concomitant medications were not reported. Past drug history included edoxaban …
Read FULL REPORT >


VACCINE TYPE(S): COVID19
VACCINE NAME(S): COVID19 (COVID19 (PFIZER-BIONTECH))


SYMPTOM(S): Gastroenteritis, SARS-CoV-2 test negative, Seizure

VAERS ID: 1000330
AGE: 37 SEX: F

Rash; Fever; Injection site swelling; Swollen lymph nodes; Dizziness; Headache; Generalized joint pain; Injection site pain; Chills; Tiredness; This is a spontaneous report from a contactable other healthcare professional (HCP) via the Regulatory Agency. Regulatory authority report number GB-MHRA-WEBCOVID-202101191104580320, Safety Report Unique Identifier GB-MHRA-ADR 24613984. A 37-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE;lot EE8492) on 04Jan2021 at single dose …
Read FULL REPORT >


VACCINE TYPE(S): COVID19
VACCINE NAME(S): COVID19 (COVID19 (PFIZER-BIONTECH))


SYMPTOM(S): Arthralgia, Lymphadenopathy, Vaccination site swelling, Chills, Pyrexia, Dizziness, Rash, Fatigue, SARS-CoV-2 test, Headache, Vaccination site pain

VAERS ID: 1000340
AGE: UNK SEX: F

Dysuria; Hyperreflexia; Extensor plantar response; Anal sphincter atony; Urinary retention; Myelitis transverse; Paraesthesia; This is a spontaneous report from a contactable physician from the regulatory authority. The regulatory authority report number is GB-MHRA-WEBCOVID-202101191454133610 with Safety Report Unique Identifier GB-MHRA-ADR 24615906. A 45-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EEG993), via an unspecified route of administration from …
Read FULL REPORT >


VACCINE TYPE(S): COVID19
VACCINE NAME(S): COVID19 (COVID19 (PFIZER-BIONTECH))


SYMPTOM(S): Anal sphincter atony, Magnetic resonance imaging, Bladder scan, Myelitis transverse, Dysuria, Paraesthesia, Extensor plantar response, SARS-CoV-2 test, Hyperreflexia, Urinary retention

Page 2 of 16157 Results 11 - 20 of 161568

Questions? Comments? Bugs?
This email address is being protected from spambots. You need JavaScript enabled to view it.
Due to the high volume of inquiries, please be patient with response times.

AND PLEASE read the FAQ first.

OpenVAERS is a private organization that posts publicly available CDC/FDA data of injuries reported post-vaccination. Reports are not proof of causality.